Why Pharma Should Commit To Population Health
Forbes April 18, 2022
Our firm has been measuring progress along the journey to population health for 7 years. That progress has been painfully slow. While the pandemic did shine a light on why we need a predictable revenue model in healthcare delivery focused on prevention and primary care, bailouts and rescues have kept a dying fee-for-service model on continued life support. Population health represents a real opportunity for providers to improve not only the health and well-being of those they serve, but also their own financial health.
However, and despite general agreement with this outlook among industry insiders, our research highlights that most providers have yet to commit themselves to a new model. Instead, the general theme has been to blame others for...